A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR (Q83398624)
Jump to navigation
Jump to search
scientific article published on 01 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR |
scientific article published on 01 February 2011 |
Statements
A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial (English)
Jarosław D Kasprzak
Christoph Bode
John H Alexander
Jan H Cornel
1 reference
Thomas J Povsic
Roxana Mehran
Christopher E Buller
Gilles Montalescot
Diane Joseph
William A Wargin
Christopher P Rusconi
Steven L Zelenkofske
Richard C Becker
1 February 2011